You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星國際(00656.HK) :積極推進復必泰疫苗內地審批 擬續增持復星醫藥
復星國際(00656.HK)董事長郭廣昌表示,復必泰疫苗內地審批進程一直得到國務院聯防聯控、國家藥監局和上海市政府等多個部門大力支持,相關事項在按正常程序積極推進,期待早日在國內上市。至於和BioNTech組建合資公司實現上海設廠本地化生產疫苗,有關工作亦有序進行。 集團高級副總裁兼首席財務官龔平指,對復星醫藥(02196.HK)價值充滿信心,上半年增持近10億元人民幣,未來有機會公司願意繼續增持更多。 近日有關部門召集白酒行業人士開會,集團執行董事兼聯席總裁徐曉亮認爲,目的是進一步規範白酒行業更有序發展,避免盲目投資造成泡沫化。長遠仍非常看好白酒行業發展,目前公司旗下投資的白酒品牌包括捨得和金徽都有清晰的發展戰略,分別會專注擴大產能和擴展市場。 另外,對於內地近日研究促進「共同富裕」,聯席董事長汪羣斌表示,共同富裕爲公司成立目標之一,例如體現在通過企業高質量發展讓員工、客戶、投資者及合作夥伴共同富裕;通過復星基金會更多地積極參與社會公益活動,包括鄉村醫生、青年創業等公益項目。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account